Aethyl-α-(4-acetamido-phenoxy)-propionat | 25899-96-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Aethyl-α-(4-acetamido-phenoxy)-propionat
• 英文别名: α-(4-Acetylamino-phenyl)-propionsaeureaethylester；Ethyl α-(4-acetylaminophenyl)-propionat；ethyl 2-(4-acetylaminophenyl)propionate；ethyl 4-acetoaminophenylpropionate；ethyl α-(4-acetylaminophenyl)-propionate；ethyl 2-(4-acetamidophenyl)propanoate
• CAS: 25899-96-1
• 化学式: C₁₃H₁₇NO₃
• 分子量: 235.283
• InChiKey: KSCPJHMXCRAJFL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Aethyl-α-(4-acetamido-phenoxy)-propionat 生成 ethyl α-(3-chloro-4-aminophenyl)-propionate
  参考文献：
  名称：

  CARNEY, R. J.;DESTEVENS, G.

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氨基苯乙酸乙酯 在 sodium hydride 、 一水合肼 作用下， 以 乙醇 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 40.0h， 生成 Aethyl-α-(4-acetamido-phenoxy)-propionat
  参考文献：
  名称：

  Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors

  摘要：

  We previously reported on a series of cyclohexanediamine derivatives as highly potent factor Xa inhibitors. Herein, we describe the modification of the spacer moiety to discover an alternative scaffold. Ethylenediamine derivatives possessing a substituent at the C1 position in S configuration and phenylenediamine derivatives possessing a substituent at the C5 position demonstrated moderate to strong anti-fXa activity. Further SAR studies led to the identification of compound 30h which showed both good in vitro activity (fXa IC50 = 2.2 nM, PTCT2 = 3.9 mu M) and in vivo antithrombotic efficacy. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.01.132

文献信息

• Benzene derivatives having NGF production-promoting activity
  申请人：Sankyo Company, Limited

  公开号：US05614521A1

  公开（公告）日：1997-03-25

  A compound of the formula (I): ##STR1## wherein R.sup.1 is an unsubstituted or substituted amino group, a protected amino group, or a nitro group; R.sup.2 is an unsubstituted or substituted amino group, a protected amino group, an unsubstituted or substituted hydroxy group or a protected hydroxy group; R.sup.3 is an unsubstituted or substituted amino group, m is 0 to 2; n is 0 to 6; with the proviso that when m is 0, then n is an integer from 2 to 6, and pharmaceutically acceptable salts thereof. Compounds of formula (I) except those wherein R.sup.1 is a nitro group have activity in promoting the production of nerve growth factor.

  化合物的化学式（I）：其中R.sup.1是未取代或取代的氨基团、保护的氨基团或硝基团；R.sup.2是未取代或取代的氨基团、保护的氨基团、未取代或取代的羟基团或保护的羟基团；R.sup.3是未取代或取代的氨基团，m为0至2；n为0至6；但当m为0时，n为2至6的整数，以及其药学上可接受的盐。化合物的化学式（I），除了R.sup.1为硝基团的化合物外，均具有促进神经生长因子产生的活性。
• Immunomodulating agent
  申请人：Nippon Shinyaku Company, Limited

  公开号：US04720506A1

  公开（公告）日：1988-01-19

  Phenylacetic acid derivatives of the formula: ##STR1## wherein R.sup.1 is hydrogen or ##STR2## wherein R.sup.5 is an alkyl group of 1-6 carbon atoms or an aryl group; R.sup.2 and R.sup.3 are independently hydrogen or an alkyl group of 1-4 carbon atoms; R.sup.4 is hydrogen or an alkyl group of 1-4 carbon atoms, have been found to possess immunomodulating activity.

  式子为：##STR1## 其中R.sup.1是氢或者##STR2## 其中R.sup.5是一个由1-6个碳原子组成的烷基或芳基；R.sup.2和R.sup.3分别是氢或者由1-4个碳原子组成的烷基；R.sup.4是氢或由1-4个碳原子组成的烷基。发现这些化合物具有免疫调节活性。
• Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
  申请人：MITSUBISHI KASEI CORPORATION

  公开号：EP0094599B1

  公开（公告）日：1987-04-01
• CARNEY, R. J.;DESTEVENS, G.
  作者：CARNEY, R. J.、DESTEVENS, G.

  DOI：——

  日期：——
• US3997669A
  申请人：——

  公开号：US3997669A

  公开（公告）日：1976-12-14